Proviron 25 is used to treat potency disturbances, infertility, and declining physical and mental alertness in the aging male due to reduced androgen formation. It is an oral androgen which does not aromatize to estrogen. It does not stimulate the body to produce testosterone but may act as an oral androgen substitute to compensate for a lack of the natural male androgen. It is suitable for treatment of all conditions caused by deficient endogenous androgen formation without impairment of spermatogenesis. It is effective as an anti-aromatase in the body, preventing or slowing the conversion of androgens into estrogens. Proviron 25 is well tolerated by the liver.
Mesterolone balances a deficiency of androgen formation, which begins to fall gradually with increasing age. It is used to treat various types of sexual dysfunction often resulting from low endogenous testosterone production. Mesterolone can in many cases reverse problems of sexual disinterest and impotency and is sometimes used to increase the sperm count. Mesterolone is suitable for treatment of all conditions caused by deficient endogenous androgen formation. In the recommended therapeutic dosage, Mesterolone will not impair spermatogenesis. Mesterolone is well tolerated by the liver.
Declining physical activity and mental alertness in the aging male: reduced efficiency, easy fatigability, lack of concentration, weak memory, disturbances of libido and potency, irritability, disturbances of sleep, depressive moods, and general vegetative complaints often attributed to androgen-deficiency are often overcome or improved with Proviron 25 use.
Potency Disturbances: Mesterolone overcomes androgen-deficiency linked potency disturbances and may provide improvement in cases of potency disturbance which are not androgen-deficiency linked.
Hypogonadism: Function and growth of androgen-dependent tissues are stimulated by Mesterolone. It may be used for androgen replacement therapy after puberty.
Reduction of Sex hormone-binding globulin (SHBG) increasing free testosterone levels.
Infertility: Treatment of oligozoospermia and insufficient Leydig-cell secretion linked infertility. Treatment can increase sperm count, quality, and fructose concentration increasing chances of fertilization.
Patients with carcinoma or suspected carcinoma of the prostate or testis should not undergo androgen therapy of any kind including the use of Proviron 25.
Proviron 25 is recommended only for male patients.
Regular examinations of the prostate should be carried out prophylactically.
Oily skin, increased body hair growth, possible hair loss at higher doses if genetically predisposed.
DOSAGE AND ADMINISTRATION
Declining physical activity and potency issues: One 25mg tablet taken orally 3 times per day for the first week and thereafter one 25mg tablet taken orally 1 to 2 times per day for a duration from 4 to 6 weeks to several months.
Hypogonadism: One 25mg tablet taken orally 2 to 3 times daily.
Oligozoospermia: One 25mg tablet taken orally 2 to 3 times daily for a full spermatogenic cycle (3 months).
25mg uncoated tablets: 50 tablet in blister strips.
Store in a cool dry place between 15 - 25oC. Protect from light.
Protect from light. Store at 15-25oC.
PRODUCT AUTHENTICATION :
NEWS / EVENTS
Magnum Pharmaceuticals Authentication
Try our new method to quickly authenticate your product using the 2D barcode.
Click the respective link to download the QR Reader app for your phone.
Please Note : We do not sell or ship to the USA, Europe, Australia or any other locations where prohibited. All information contained within this website or in any literature provided is not a prescription to use. Please seek the advice of a physician specializing in Andrology before use.
Not affiliated with Magnum Pharma (USA), Magnum Pharmaceuticals Inc. (USA), Magnum Chemi-Tech Ltd., or Magnum Nutraceuticals (Asia) Pte Ltd.
Distributors must submit licensing, a company profile, and our completed distributor application for approval prior to ordering.